img

Global Pregabalin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pregabalin Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Pregabalin is an anticonvulsant drug used for the treatment of epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. Its mode of action involves decrease in pain signals sent by the damaged nerves in the body.
Pregabalin report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Pregabalin market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Clinics are the major drivers for the industry.
Increase in geriatric population suffering from neuropathic diabetes and rise in prevalence of diabetes, HIV, cancer, epilepsy, fibromyalgia, and other such disorders are expected to drive the Pregabalin market. 
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Pregabalin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


ZCL Chemicals
Olon S.p.A.
AASraw Biochemical Technology
Changzhou Pharmaceutical Factory (CPF)
Almelo Pvt. Ltd.
Divi’s Laboratories
Angels Pharma
ARITE Pharmaceutical
BAL Pharma
Bazayan
Aurobindo Pharma
Hikal
Glenmark Life Sciences
Dongbang FTL
Teva Pharmaceutical Industries
Divi’s Laboratories
Chemo Iberica
Maps Laboratories
Laurus Labs
Zhejiang Huahai Pharmaceutical
Vasudha Pharma Chem
Sun Pharmaceutical Industries
CTX Life Sciences
Srini Pharmaceuticals
Segment by Type
Tablet
Capsule
Oral Solution

Segment by Application


Hospitals
Clinics
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Pregabalin market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Pregabalin, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Pregabalin industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Pregabalin in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Pregabalin introduction, etc. Pregabalin Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Pregabalin market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Pregabalin Market Overview
1.1 Pregabalin Product Overview
1.2 Pregabalin Market Segment by Type
1.2.1 Tablet
1.2.2 Capsule
1.2.3 Oral Solution
1.3 Global Pregabalin Market Size by Type
1.3.1 Global Pregabalin Market Size Overview by Type (2018-2034)
1.3.2 Global Pregabalin Historic Market Size Review by Type (2018-2024)
1.3.3 Global Pregabalin Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Pregabalin Sales Breakdown by Type (2018-2024)
1.4.2 Europe Pregabalin Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Pregabalin Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Pregabalin Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Pregabalin Sales Breakdown by Type (2018-2024)
2 Global Pregabalin Market Competition by Company
2.1 Global Top Players by Pregabalin Sales (2018-2024)
2.2 Global Top Players by Pregabalin Revenue (2018-2024)
2.3 Global Top Players by Pregabalin Price (2018-2024)
2.4 Global Top Manufacturers Pregabalin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Pregabalin Market Competitive Situation and Trends
2.5.1 Pregabalin Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Pregabalin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pregabalin as of 2022)
2.7 Date of Key Manufacturers Enter into Pregabalin Market
2.8 Key Manufacturers Pregabalin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Pregabalin Status and Outlook by Region
3.1 Global Pregabalin Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Pregabalin Historic Market Size by Region
3.2.1 Global Pregabalin Sales in Volume by Region (2018-2024)
3.2.2 Global Pregabalin Sales in Value by Region (2018-2024)
3.2.3 Global Pregabalin Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Pregabalin Forecasted Market Size by Region
3.3.1 Global Pregabalin Sales in Volume by Region (2024-2034)
3.3.2 Global Pregabalin Sales in Value by Region (2024-2034)
3.3.3 Global Pregabalin Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Pregabalin by Application
4.1 Pregabalin Market Segment by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Pregabalin Market Size by Application
4.2.1 Global Pregabalin Market Size Overview by Application (2018-2034)
4.2.2 Global Pregabalin Historic Market Size Review by Application (2018-2024)
4.2.3 Global Pregabalin Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Pregabalin Sales Breakdown by Application (2018-2024)
4.3.2 Europe Pregabalin Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Pregabalin Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Pregabalin Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Pregabalin Sales Breakdown by Application (2018-2024)
5 North America Pregabalin by Country
5.1 North America Pregabalin Historic Market Size by Country
5.1.1 North America Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Pregabalin Sales in Volume by Country (2018-2024)
5.1.3 North America Pregabalin Sales in Value by Country (2018-2024)
5.2 North America Pregabalin Forecasted Market Size by Country
5.2.1 North America Pregabalin Sales in Volume by Country (2024-2034)
5.2.2 North America Pregabalin Sales in Value by Country (2024-2034)
6 Europe Pregabalin by Country
6.1 Europe Pregabalin Historic Market Size by Country
6.1.1 Europe Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Pregabalin Sales in Volume by Country (2018-2024)
6.1.3 Europe Pregabalin Sales in Value by Country (2018-2024)
6.2 Europe Pregabalin Forecasted Market Size by Country
6.2.1 Europe Pregabalin Sales in Volume by Country (2024-2034)
6.2.2 Europe Pregabalin Sales in Value by Country (2024-2034)
7 Asia-Pacific Pregabalin by Region
7.1 Asia-Pacific Pregabalin Historic Market Size by Region
7.1.1 Asia-Pacific Pregabalin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Pregabalin Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Pregabalin Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Pregabalin Forecasted Market Size by Region
7.2.1 Asia-Pacific Pregabalin Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Pregabalin Sales in Value by Region (2024-2034)
8 Latin America Pregabalin by Country
8.1 Latin America Pregabalin Historic Market Size by Country
8.1.1 Latin America Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Pregabalin Sales in Volume by Country (2018-2024)
8.1.3 Latin America Pregabalin Sales in Value by Country (2018-2024)
8.2 Latin America Pregabalin Forecasted Market Size by Country
8.2.1 Latin America Pregabalin Sales in Volume by Country (2024-2034)
8.2.2 Latin America Pregabalin Sales in Value by Country (2024-2034)
9 Middle East and Africa Pregabalin by Country
9.1 Middle East and Africa Pregabalin Historic Market Size by Country
9.1.1 Middle East and Africa Pregabalin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Pregabalin Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Pregabalin Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Pregabalin Forecasted Market Size by Country
9.2.1 Middle East and Africa Pregabalin Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Pregabalin Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 ZCL Chemicals
10.1.1 ZCL Chemicals Company Information
10.1.2 ZCL Chemicals Introduction and Business Overview
10.1.3 ZCL Chemicals Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.1.4 ZCL Chemicals Pregabalin Products Offered
10.1.5 ZCL Chemicals Recent Development
10.2 Olon S.p.A.
10.2.1 Olon S.p.A. Company Information
10.2.2 Olon S.p.A. Introduction and Business Overview
10.2.3 Olon S.p.A. Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Olon S.p.A. Pregabalin Products Offered
10.2.5 Olon S.p.A. Recent Development
10.3 AASraw Biochemical Technology
10.3.1 AASraw Biochemical Technology Company Information
10.3.2 AASraw Biochemical Technology Introduction and Business Overview
10.3.3 AASraw Biochemical Technology Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.3.4 AASraw Biochemical Technology Pregabalin Products Offered
10.3.5 AASraw Biochemical Technology Recent Development
10.4 Changzhou Pharmaceutical Factory (CPF)
10.4.1 Changzhou Pharmaceutical Factory (CPF) Company Information
10.4.2 Changzhou Pharmaceutical Factory (CPF) Introduction and Business Overview
10.4.3 Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Changzhou Pharmaceutical Factory (CPF) Pregabalin Products Offered
10.4.5 Changzhou Pharmaceutical Factory (CPF) Recent Development
10.5 Almelo Pvt. Ltd.
10.5.1 Almelo Pvt. Ltd. Company Information
10.5.2 Almelo Pvt. Ltd. Introduction and Business Overview
10.5.3 Almelo Pvt. Ltd. Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Almelo Pvt. Ltd. Pregabalin Products Offered
10.5.5 Almelo Pvt. Ltd. Recent Development
10.6 Divi’s Laboratories
10.6.1 Divi’s Laboratories Company Information
10.6.2 Divi’s Laboratories Introduction and Business Overview
10.6.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Divi’s Laboratories Pregabalin Products Offered
10.6.5 Divi’s Laboratories Recent Development
10.7 Angels Pharma
10.7.1 Angels Pharma Company Information
10.7.2 Angels Pharma Introduction and Business Overview
10.7.3 Angels Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Angels Pharma Pregabalin Products Offered
10.7.5 Angels Pharma Recent Development
10.8 ARITE Pharmaceutical
10.8.1 ARITE Pharmaceutical Company Information
10.8.2 ARITE Pharmaceutical Introduction and Business Overview
10.8.3 ARITE Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.8.4 ARITE Pharmaceutical Pregabalin Products Offered
10.8.5 ARITE Pharmaceutical Recent Development
10.9 BAL Pharma
10.9.1 BAL Pharma Company Information
10.9.2 BAL Pharma Introduction and Business Overview
10.9.3 BAL Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.9.4 BAL Pharma Pregabalin Products Offered
10.9.5 BAL Pharma Recent Development
10.10 Bazayan
10.10.1 Bazayan Company Information
10.10.2 Bazayan Introduction and Business Overview
10.10.3 Bazayan Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Bazayan Pregabalin Products Offered
10.10.5 Bazayan Recent Development
10.11 Aurobindo Pharma
10.11.1 Aurobindo Pharma Company Information
10.11.2 Aurobindo Pharma Introduction and Business Overview
10.11.3 Aurobindo Pharma Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Aurobindo Pharma Pregabalin Products Offered
10.11.5 Aurobindo Pharma Recent Development
10.12 Hikal
10.12.1 Hikal Company Information
10.12.2 Hikal Introduction and Business Overview
10.12.3 Hikal Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Hikal Pregabalin Products Offered
10.12.5 Hikal Recent Development
10.13 Glenmark Life Sciences
10.13.1 Glenmark Life Sciences Company Information
10.13.2 Glenmark Life Sciences Introduction and Business Overview
10.13.3 Glenmark Life Sciences Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Glenmark Life Sciences Pregabalin Products Offered
10.13.5 Glenmark Life Sciences Recent Development
10.14 Dongbang FTL
10.14.1 Dongbang FTL Company Information
10.14.2 Dongbang FTL Introduction and Business Overview
10.14.3 Dongbang FTL Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Dongbang FTL Pregabalin Products Offered
10.14.5 Dongbang FTL Recent Development
10.15 Teva Pharmaceutical Industries
10.15.1 Teva Pharmaceutical Industries Company Information
10.15.2 Teva Pharmaceutical Industries Introduction and Business Overview
10.15.3 Teva Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Teva Pharmaceutical Industries Pregabalin Products Offered
10.15.5 Teva Pharmaceutical Industries Recent Development
10.16 Divi’s Laboratories
10.16.1 Divi’s Laboratories Company Information
10.16.2 Divi’s Laboratories Introduction and Business Overview
10.16.3 Divi’s Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Divi’s Laboratories Pregabalin Products Offered
10.16.5 Divi’s Laboratories Recent Development
10.17 Chemo Iberica
10.17.1 Chemo Iberica Company Information
10.17.2 Chemo Iberica Introduction and Business Overview
10.17.3 Chemo Iberica Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Chemo Iberica Pregabalin Products Offered
10.17.5 Chemo Iberica Recent Development
10.18 Maps Laboratories
10.18.1 Maps Laboratories Company Information
10.18.2 Maps Laboratories Introduction and Business Overview
10.18.3 Maps Laboratories Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Maps Laboratories Pregabalin Products Offered
10.18.5 Maps Laboratories Recent Development
10.19 Laurus Labs
10.19.1 Laurus Labs Company Information
10.19.2 Laurus Labs Introduction and Business Overview
10.19.3 Laurus Labs Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Laurus Labs Pregabalin Products Offered
10.19.5 Laurus Labs Recent Development
10.20 Zhejiang Huahai Pharmaceutical
10.20.1 Zhejiang Huahai Pharmaceutical Company Information
10.20.2 Zhejiang Huahai Pharmaceutical Introduction and Business Overview
10.20.3 Zhejiang Huahai Pharmaceutical Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Zhejiang Huahai Pharmaceutical Pregabalin Products Offered
10.20.5 Zhejiang Huahai Pharmaceutical Recent Development
10.21 Vasudha Pharma Chem
10.21.1 Vasudha Pharma Chem Company Information
10.21.2 Vasudha Pharma Chem Introduction and Business Overview
10.21.3 Vasudha Pharma Chem Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Vasudha Pharma Chem Pregabalin Products Offered
10.21.5 Vasudha Pharma Chem Recent Development
10.22 Sun Pharmaceutical Industries
10.22.1 Sun Pharmaceutical Industries Company Information
10.22.2 Sun Pharmaceutical Industries Introduction and Business Overview
10.22.3 Sun Pharmaceutical Industries Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Sun Pharmaceutical Industries Pregabalin Products Offered
10.22.5 Sun Pharmaceutical Industries Recent Development
10.23 CTX Life Sciences
10.23.1 CTX Life Sciences Company Information
10.23.2 CTX Life Sciences Introduction and Business Overview
10.23.3 CTX Life Sciences Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.23.4 CTX Life Sciences Pregabalin Products Offered
10.23.5 CTX Life Sciences Recent Development
10.24 Srini Pharmaceuticals
10.24.1 Srini Pharmaceuticals Company Information
10.24.2 Srini Pharmaceuticals Introduction and Business Overview
10.24.3 Srini Pharmaceuticals Pregabalin Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Srini Pharmaceuticals Pregabalin Products Offered
10.24.5 Srini Pharmaceuticals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Pregabalin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Pregabalin Industrial Chain Analysis
11.4 Pregabalin Market Dynamics
11.4.1 Pregabalin Industry Trends
11.4.2 Pregabalin Market Drivers
11.4.3 Pregabalin Market Challenges
11.4.4 Pregabalin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Pregabalin Distributors
12.3 Pregabalin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tablet
Table 2. Major Company of Capsule
Table 3. Major Company of Oral Solution
Table 4. Global Pregabalin Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Pregabalin Sales by Type (2018-2024) & (K MT)
Table 6. Global Pregabalin Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Pregabalin Sales by Type (2018-2024) & (US& Million)
Table 8. Global Pregabalin Market Share in Value by Type (2018-2024)
Table 9. Global Pregabalin Price by Type (2018-2024) & (USD/MT)
Table 10. Global Pregabalin Sales by Type (2024-2034) & (K MT)
Table 11. Global Pregabalin Sales Market Share in Volume by Type (2024-2034)
Table 12. Global Pregabalin Sales by Type (2024-2034) & (US$ Million)
Table 13. Global Pregabalin Sales Market Share in Value by Type (2024-2034)
Table 14. Global Pregabalin Price by Type (2024-2034) & (USD/MT)
Table 15. North America Pregabalin Sales by Type (2018-2024) & (K MT)
Table 16. North America Pregabalin Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Pregabalin Sales (K MT) by Type (2018-2024)
Table 18. Europe Pregabalin Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Pregabalin Sales (K MT) by Type (2018-2024)
Table 20. Asia-Pacific Pregabalin Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Pregabalin Sales (K MT) by Type (2018-2024)
Table 22. Latin America Pregabalin Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Pregabalin Sales (K MT) by Type (2018-2024)
Table 24. Middle East and Africa Pregabalin Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Pregabalin Sales by Company (2018-2024) & (K MT)
Table 26. Global Pregabalin Sales Share by Company (2018-2024)
Table 27. Global Pregabalin Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Pregabalin Revenue Share by Company (2018-2024)
Table 29. Global Market Pregabalin Price by Company (2018-2024) & (USD/MT)
Table 30. Global Pregabalin Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Pregabalin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pregabalin as of 2022)
Table 33. Date of Key Manufacturers Enter into Pregabalin Market
Table 34. Key Manufacturers Pregabalin Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Pregabalin Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 37. Global Pregabalin Sales by Region (2018-2024) & (K MT)
Table 38. Global Pregabalin Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Pregabalin Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Pregabalin Sales Market Share in Value by Region (2018-2024)
Table 41. Global Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2024)
Table 42. Global Pregabalin Sales by Region (2024-2034) & (K MT)
Table 43. Global Pregabalin Sales Market Share in Volume by Region (2024-2034)
Table 44. Global Pregabalin Sales by Region (2024-2034) & (US$ Million)
Table 45. Global Pregabalin Sales Market Share in Value by Region (2024-2034)
Table 46. Global Pregabalin Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2024-2034)
Table 47. Global Pregabalin Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 48. Global Pregabalin Sales by Application (2018-2024) & (K MT)
Table 49. Global Pregabalin Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Pregabalin Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Pregabalin Sales Market Share in Value by Application (2018-2024)
Table 52. Global Pregabalin Price by Application (2018-2024) & (USD/MT)
Table 53. Global Pregabalin Sales by Application (2024-2034) & (K MT)
Table 54. Global Pregabalin Sales Market Share in Volume by Application (2024-2034)
Table 55. Global Pregabalin Sales by Application (2024-2034) & (US$ Million)
Table 56. Global Pregabalin Sales Market Share in Value by Application (2024-2034)
Table 57. Global Pregabalin Price by Application (2024-2034) & (USD/MT)
Table 58. North America Pregabalin Sales by Application (2018-2024) (K MT)
Table 59. North America Pregabalin Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Pregabalin Sales by Application (2018-2024) (K MT)
Table 61. Europe Pregabalin Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Pregabalin Sales by Application (2018-2024) (K MT)
Table 63. Asia-Pacific Pregabalin Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Pregabalin Sales by Application (2018-2024) (K MT)
Table 65. Latin America Pregabalin Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Pregabalin Sales by Application (2018-2024) (K MT)
Table 67. Middle East and Africa Pregabalin Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Pregabalin Sales by Country (2018-2024) & (K MT)
Table 69. North America Pregabalin Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Pregabalin Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Pregabalin Sales Market Share in Value by Country (2018-2024)
Table 72. North America Pregabalin Sales by Country (2024-2034) & (K MT)
Table 73. North America Pregabalin Sales Market Share in Volume by Country (2024-2034)
Table 74. North America Pregabalin Sales by Country (2024-2034) & (US$ Million)
Table 75. North America Pregabalin Sales Market Share in Value by Country (2024-2034)
Table 76. Europe Pregabalin Sales by Country (2018-2024) & (K MT)
Table 77. Europe Pregabalin Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Pregabalin Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Pregabalin Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Pregabalin Sales by Country (2024-2034) & (K MT)
Table 81. Europe Pregabalin Sales Market Share in Volume by Country (2024-2034)
Table 82. Europe Pregabalin Sales by Country (2024-2034) & (US$ Million)
Table 83. Europe Pregabalin Sales Market Share in Value by Country (2024-2034)
Table 84. Asia-Pacific Pregabalin Sales by Region (2018-2024) & (K MT)
Table 85. Asia-Pacific Pregabalin Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Pregabalin Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Pregabalin Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Pregabalin Sales by Region (2024-2034) & (K MT)
Table 89. Asia-Pacific Pregabalin Sales Market Share in Volume by Region (2024-2034)
Table 90. Asia-Pacific Pregabalin Sales by Region (2024-2034) & (US$ Million)
Table 91. Asia-Pacific Pregabalin Sales Market Share in Value by Region (2024-2034)
Table 92. Latin America Pregabalin Sales by Country (2018-2024) & (K MT)
Table 93. Latin America Pregabalin Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Pregabalin Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Pregabalin Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Pregabalin Sales by Country (2024-2034) & (K MT)
Table 97. Latin America Pregabalin Sales Market Share in Volume by Country (2024-2034)
Table 98. Latin America Pregabalin Sales by Country (2024-2034) & (US$ Million)
Table 99. Latin America Pregabalin Sales Market Share in Value by Country (2024-2034)
Table 100. Middle East and Africa Pregabalin Sales by Country (2018-2024) & (K MT)
Table 101. Middle East and Africa Pregabalin Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Pregabalin Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Pregabalin Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Pregabalin Sales by Country (2024-2034) & (K MT)
Table 105. Middle East and Africa Pregabalin Sales Market Share in Volume by Country (2024-2034)
Table 106. Middle East and Africa Pregabalin Sales by Country (2024-2034) & (US$ Million)
Table 107. Middle East and Africa Pregabalin Sales Market Share in Value by Country (2024-2034)
Table 108. ZCL Chemicals Company Information
Table 109. ZCL Chemicals Introduction and Business Overview
Table 110. ZCL Chemicals Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 111. ZCL Chemicals Pregabalin Product
Table 112. ZCL Chemicals Recent Development
Table 113. Olon S.p.A. Company Information
Table 114. Olon S.p.A. Introduction and Business Overview
Table 115. Olon S.p.A. Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 116. Olon S.p.A. Pregabalin Product
Table 117. Olon S.p.A. Recent Development
Table 118. AASraw Biochemical Technology Company Information
Table 119. AASraw Biochemical Technology Introduction and Business Overview
Table 120. AASraw Biochemical Technology Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 121. AASraw Biochemical Technology Pregabalin Product
Table 122. AASraw Biochemical Technology Recent Development
Table 123. Changzhou Pharmaceutical Factory (CPF) Company Information
Table 124. Changzhou Pharmaceutical Factory (CPF) Introduction and Business Overview
Table 125. Changzhou Pharmaceutical Factory (CPF) Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 126. Changzhou Pharmaceutical Factory (CPF) Pregabalin Product
Table 127. Changzhou Pharmaceutical Factory (CPF) Recent Development
Table 128. Almelo Pvt. Ltd. Company Information
Table 129. Almelo Pvt. Ltd. Introduction and Business Overview
Table 130. Almelo Pvt. Ltd. Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 131. Almelo Pvt. Ltd. Pregabalin Product
Table 132. Almelo Pvt. Ltd. Recent Development
Table 133. Divi’s Laboratories Company Information
Table 134. Divi’s Laboratories Introduction and Business Overview
Table 135. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 136. Divi’s Laboratories Pregabalin Product
Table 137. Divi’s Laboratories Recent Development
Table 138. Angels Pharma Company Information
Table 139. Angels Pharma Introduction and Business Overview
Table 140. Angels Pharma Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 141. Angels Pharma Pregabalin Product
Table 142. Angels Pharma Recent Development
Table 143. ARITE Pharmaceutical Company Information
Table 144. ARITE Pharmaceutical Introduction and Business Overview
Table 145. ARITE Pharmaceutical Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 146. ARITE Pharmaceutical Pregabalin Product
Table 147. ARITE Pharmaceutical Recent Development
Table 148. BAL Pharma Company Information
Table 149. BAL Pharma Introduction and Business Overview
Table 150. BAL Pharma Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 151. BAL Pharma Pregabalin Product
Table 152. BAL Pharma Recent Development
Table 153. Bazayan Company Information
Table 154. Bazayan Introduction and Business Overview
Table 155. Bazayan Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 156. Bazayan Pregabalin Product
Table 157. Bazayan Recent Development
Table 158. Aurobindo Pharma Company Information
Table 159. Aurobindo Pharma Introduction and Business Overview
Table 160. Aurobindo Pharma Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 161. Aurobindo Pharma Pregabalin Product
Table 162. Aurobindo Pharma Recent Development
Table 163. Hikal Company Information
Table 164. Hikal Introduction and Business Overview
Table 165. Hikal Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 166. Hikal Pregabalin Product
Table 167. Hikal Recent Development
Table 168. Glenmark Life Sciences Company Information
Table 169. Glenmark Life Sciences Introduction and Business Overview
Table 170. Glenmark Life Sciences Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 171. Glenmark Life Sciences Pregabalin Product
Table 172. Glenmark Life Sciences Recent Development
Table 173. Dongbang FTL Company Information
Table 174. Dongbang FTL Introduction and Business Overview
Table 175. Dongbang FTL Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 176. Dongbang FTL Pregabalin Product
Table 177. Dongbang FTL Recent Development
Table 178. Teva Pharmaceutical Industries Company Information
Table 179. Teva Pharmaceutical Industries Introduction and Business Overview
Table 180. Teva Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 181. Teva Pharmaceutical Industries Pregabalin Product
Table 182. Teva Pharmaceutical Industries Recent Development
Table 183. Divi’s Laboratories Company Information
Table 184. Divi’s Laboratories Introduction and Business Overview
Table 185. Divi’s Laboratories Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 186. Divi’s Laboratories Pregabalin Product
Table 187. Divi’s Laboratories Recent Development
Table 188. Chemo Iberica Company Information
Table 189. Chemo Iberica Introduction and Business Overview
Table 190. Chemo Iberica Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 191. Chemo Iberica Pregabalin Product
Table 192. Chemo Iberica Recent Development
Table 193. Maps Laboratories Company Information
Table 194. Maps Laboratories Introduction and Business Overview
Table 195. Maps Laboratories Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 196. Maps Laboratories Pregabalin Product
Table 197. Maps Laboratories Recent Development
Table 198. Laurus Labs Company Information
Table 199. Laurus Labs Introduction and Business Overview
Table 200. Laurus Labs Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 201. Laurus Labs Pregabalin Product
Table 202. Laurus Labs Recent Development
Table 203. Zhejiang Huahai Pharmaceutical Company Information
Table 204. Zhejiang Huahai Pharmaceutical Introduction and Business Overview
Table 205. Zhejiang Huahai Pharmaceutical Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 206. Zhejiang Huahai Pharmaceutical Pregabalin Product
Table 207. Zhejiang Huahai Pharmaceutical Recent Development
Table 208. Vasudha Pharma Chem Company Information
Table 209. Vasudha Pharma Chem Introduction and Business Overview
Table 210. Vasudha Pharma Chem Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 211. Vasudha Pharma Chem Pregabalin Product
Table 212. Vasudha Pharma Chem Recent Development
Table 213. Sun Pharmaceutical Industries Company Information
Table 214. Sun Pharmaceutical Industries Introduction and Business Overview
Table 215. Sun Pharmaceutical Industries Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 216. Sun Pharmaceutical Industries Pregabalin Product
Table 217. Sun Pharmaceutical Industries Recent Development
Table 218. CTX Life Sciences Company Information
Table 219. CTX Life Sciences Introduction and Business Overview
Table 220. CTX Life Sciences Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 221. CTX Life Sciences Pregabalin Product
Table 222. CTX Life Sciences Recent Development
Table 223. Srini Pharmaceuticals Company Information
Table 224. Srini Pharmaceuticals Introduction and Business Overview
Table 225. Srini Pharmaceuticals Pregabalin Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2018-2024)
Table 226. Srini Pharmaceuticals Pregabalin Product
Table 227. Srini Pharmaceuticals Recent Development
Table 228. Key Raw Materials Lists
Table 229. Raw Materials Key Suppliers Lists
Table 230. Pregabalin Market Trends
Table 231. Pregabalin Market Drivers
Table 232. Pregabalin Market Challenges
Table 233. Pregabalin Market Restraints
Table 234. Pregabalin Distributors List
Table 235. Pregabalin Downstream Customers
Table 236. Research Programs/Design for This Report
Table 237. Key Data Information from Secondary Sources
Table 238. Key Data Information from Primary Sources
List of Figures
Figure 1. Pregabalin Product Picture
Figure 2. Global Pregabalin Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Pregabalin Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Pregabalin Sales Status and Outlook (2018-2034) & (K MT)
Figure 5. Product Picture of Tablet
Figure 6. Global Tablet Sales YoY Growth (2018-2034) & (K MT)
Figure 7. Product Picture of Capsule
Figure 8. Global Capsule Sales YoY Growth (2018-2034) & (K MT)
Figure 9. Product Picture of Oral Solution
Figure 10. Global Oral Solution Sales YoY Growth (2018-2034) & (K MT)
Figure 11. Global Pregabalin Sales by Type (2018-2034) & (US$ Million)
Figure 12. Global Pregabalin Sales Market Share by Type in 2022 & 2034
Figure 13. North America Pregabalin Sales Market Share in Volume by Type in 2022
Figure 14. North America Pregabalin Sales Market Share in Value by Type in 2022
Figure 15. Europe Pregabalin Sales Market Share in Volume by Type in 2022
Figure 16. Europe Pregabalin Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Pregabalin Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Pregabalin Sales Market Share in Value by Type in 2022
Figure 19. Latin America Pregabalin Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Pregabalin Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Pregabalin Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Pregabalin Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Pregabalin Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Pregabalin Revenue in 2022
Figure 25. Pregabalin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospitals
Figure 27. Global Hospitals Sales YoY Growth (2018-2034) & (K MT)
Figure 28. Product Picture of Clinics
Figure 29. Global Clinics Sales YoY Growth (2018-2034) & (K MT)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2034) & (K MT)
Figure 32. Global Pregabalin Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Pregabalin Sales Market Share by Application in 2022 & 2034
Figure 34. North America Pregabalin Sales Market Share in Volume by Application in 2022
Figure 35. North America Pregabalin Sales Market Share in Value by Application in 2022
Figure 36. Europe Pregabalin Sales Market Share in Volume by Application in 2022
Figure 37. Europe Pregabalin Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Pregabalin Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Pregabalin Sales Market Share in Value by Application in 2022
Figure 40. Latin America Pregabalin Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Pregabalin Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Pregabalin Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Pregabalin Manufacturing Cost Structure
Figure 45. Pregabalin Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed